Cc1n[nH]c2c1C1(CCC(c3ccccc3)CC1)C(C#N)=C(N)O2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?